Skip to content
SentinelMarket desk
Switch to dark mode

일성아이에스

003120KOSPIView the 제약 sectorTheme Bio & healthcare

21,900KRWMarket close of 10/21 (Wed)

Down -0.23%-50KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)21,800KRWDown -0.46%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
21,700
High
21,900
Low
21,600
Day range
Day range low 21,600 high 21,900, open 21,700, close 21,900, previous close 21,950
Volume
0×10K shares
38.13 million KRW 0.29× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 18,300 to 28,300 won, 36% up from the low

36% of the way up from the lowest close in 1 year (252 sessions) · -22.6% from the high

Usual range

Nothing unusual in the 3 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-0.23%usual range
  • Trading value0.3×usual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.